Table 2

Clinical outcomes in patients with atrial fibrillation (AF) according to the periodontitis at 18-month follow-up

VariablesPeriodontitis group (n=47)Non-periodontitis group (n=180)P values
Follow-up duration (months)16.9±10.319.1±15.00.349
 MACE (%)40 (85.1)44 (24.6)<0.001
 Total death (%)1 (2.3)1 (0.6)0.356
   Cardiac death (%)1 (2.3)1 (0.6)
 Total thromboembolic events (%)14 (29.8)1 (0.6)<0.001
  CVA (new onset, %)12 (25.8)0 (0)
  Peripheral thromboembolism (%)2 (4.0)1 (0.6)
 Bleeding complications (%)3 (6.8)13 (7.3)1.000
 Arrhythmic events (%)44 (93.6)31 (17.4)<0.001
   SVT including AF, AFL or ATach (%)44 (93.6)30 (16.9)
  VPC or VTach (%)0 (0)1 (0.5)
 Treatment of AF
 DC cardioversion for rhythm control (%)7 (14.5)18 (10.5)0.042
  • Values are mean ±SD (range).

  • AFL, atrial flutter; ATach, atrial tachycardia; CVA, cerebrovascular accidents; MACE, major adverse cardiac events; SVT, supraventricular tachycardia; VPC, ventricular premature complex; VTach, ventricular tachycardia.